Anand Bhaskar 4
4 · Summit Therapeutics Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-12+75,000→ 75,000 totalExercise: $17.85Exp: 2035-01-12→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]The option was granted on January 12, 2025. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on January 12, 2026.
- [F2]Not Applicable.